Zantac “Impatient Guy” Settles Down Following Negative NAD Verdict
This article was originally published in The Tan Sheet
Executive Summary
Pfizer appears to have modified a TV advertisement for its H2-antagonist Zantac 150 to reflect a recent NAD ruling that found the commercial misleading